Works matching IS 27696456 AND DT 2023 AND VI 2 AND IP 3
Results: 10
Issue Information.
- Published in:
- Medcomm: Future Medicine, 2023, v. 2, n. 3, p. 1, doi. 10.1002/mef2.9
- Publication type:
- Article
Small‐molecule drugs as RNA‐targeted degraders.
- Published in:
- Medcomm: Future Medicine, 2023, v. 2, n. 3, p. 1, doi. 10.1002/mef2.60
- By:
- Publication type:
- Article
Metabolic insights into tumor pathogenesis: Unveiling pan‐cancer metabolism and the potential of untargeted metabolomics.
- Published in:
- Medcomm: Future Medicine, 2023, v. 2, n. 3, p. 1, doi. 10.1002/mef2.59
- By:
- Publication type:
- Article
The molecular mechanism of Xiaoxuming decoction in the treatment of ischemic stroke based on network pharmacology and molecular docking.
- Published in:
- Medcomm: Future Medicine, 2023, v. 2, n. 3, p. 1, doi. 10.1002/mef2.58
- By:
- Publication type:
- Article
Comparative in silico, in vitro and ex vivo anti‐inflammatory activity of quercetin.
- Published in:
- Medcomm: Future Medicine, 2023, v. 2, n. 3, p. 1, doi. 10.1002/mef2.57
- By:
- Publication type:
- Article
Chemoimmunotherapy for esophageal squamous cell carcinoma—Summary and discussion of recent clinical trials.
- Published in:
- Medcomm: Future Medicine, 2023, v. 2, n. 3, p. 1, doi. 10.1002/mef2.56
- By:
- Publication type:
- Article
Causality between COVID‐19 and female reproductive function: A Mendelian randomization study.
- Published in:
- Medcomm: Future Medicine, 2023, v. 2, n. 3, p. 1, doi. 10.1002/mef2.55
- By:
- Publication type:
- Article
The epidemiological and clinical characteristics of COVID‐19 patients admitted to a Fangcang shelter hospital in Beijing before the change in China's prevention and control policy.
- Published in:
- Medcomm: Future Medicine, 2023, v. 2, n. 3, p. 1, doi. 10.1002/mef2.54
- By:
- Publication type:
- Article
PM2.5 air pollutant drives the initiate of lung adenocarcinoma.
- Published in:
- Medcomm: Future Medicine, 2023, v. 2, n. 3, p. 1, doi. 10.1002/mef2.53
- By:
- Publication type:
- Article
Computational study unravels inhibitory potential of epicatechin gallate against inflammatory and pyroptosis‐associated mediators in COVID‐19.
- Published in:
- Medcomm: Future Medicine, 2023, v. 2, n. 3, p. 1, doi. 10.1002/mef2.52
- By:
- Publication type:
- Article